Eden Research

Eden Research PLC Eden Research plc is an AIM-listed public company with intellectual property and expertise in microencapsulation, terpenes and environmentally friendly technologies. We are developing these technologies through innovative research and a series of appropriate commercial production, marketing and distribution partnerships. Based in Cirencester in the UK, we are developing natural solutions to agricultural, animal, human health and industrial problems, with our primary focus being the use of terpenes to create an exciting array of low-risk but effective agricultural chemicals. Eden's products take advantage of the biocidal efficacy of naturally occurring chemicals produced by plant defence mechanisms and, in particular, the antimicrobial properties of terpenes. Terpenes are naturally occurring, low-toxicity botanical substances produced by most plants as part of their defence mechanisms. The initial Eden approach has involved the use of GRAS substances, that is, compounds 'Generally Recogised As Safe' for human consumption or application to food crops. Board of Directors: - Tom Lupton, Non-executive Chairman - Sean Smith, Chief Executive Officer - Alexander John Abrey, Chief Financial Officer - Robin Cridland, Non-executive Director Company No. 03071324
Cirencester, GB
Size (employees)
5 (est)-16%
Eden Research was founded in 1996 and is headquartered in Cirencester, GB

Eden Research Office Locations

Eden Research has offices in Cirencester and London
Cirencester, GB (HQ)
3 15 Gosditch St
London, GB
Walbrook PR Ltd 4 Lombard Street

Eden Research Data and Metrics

Eden Research Financial Metrics

Eden Research's revenue was reported to be £392 k in FY, 2016 which is a 56% decrease from the previous period.

Revenue (FY, 2016)

392 k

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

363.4 k

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(1.8 m)

Market capitalization (25-Sep-2017)

22.2 m

Closing share price (25-Sep-2017)


Cash (31-Dec-2016)

1.5 m
Eden Research's current market capitalization is £22.2 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


80.2 k99.9 k883.3 k392 k

Revenue growth, %


Cost of goods sold

98.7 k28.6 k

Gross profit

784.6 k363.4 k
GBPFY, 2013FY, 2014FY, 2015FY, 2016


311.3 k415 k148.4 k1.5 m

Accounts Receivable

117.5 k34.4 k145 k236.1 k

Current Assets

441.1 k477.5 k312.8 k1.8 m


923.1 k811.2 k
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(1.2 m)(930.3 k)(104.9 k)(917 k)

Cash From Financing Activities

1.4 m1.5 m(30 k)2.5 m

Income Taxes Paid

40.3 k28.3 k101.3 k81.9 k
Y, 2016

Financial Leverage

1.2 x
Show all financial metrics

Eden Research Market Value History

Eden Research Revenue Breakdown

Traffic Overview of Eden Research

Eden Research Online and Social Media Presence

Eden Research Company Life and Culture

You may also be interested in